ALGN · Full Picture

ALIGN TECHNOLOGY INC — the full picture

Earnings window · 2026-07-15 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Hyderabad Manufacturing Expansion · Capacity & footprint expansionPriority 68
    2 sources (news, sec_filing); quote_verified
    Align announced plans to open its first manufacturing facility in Hyderabad, India, by next year involving a $200 million investment and creating over 300 jobs, expected to be operational in 2027.
  2. Litigation and Legal Risk · Litigation & settlementsPriority 68
    -6.6% net_income (realized); quote_verified
    For the six months ended June 30, 2026, legal settlements and contingencies recorded: $69.3 million, consisting of $31.8 million legal settlements and $37.5 million UK VAT contingency loss.
  3. Capital Expenditure Outlook · UnclassifiedPriority 67
    -1.8% cash; 1 forward row(s); structured_verified
    Company expects investments in capital expenditures for fiscal year 2026 to be $125 million to $150 million.
  4. Hyderabad Manufacturing Investment · UnclassifiedPriority 67
    -1.6% cash; 2 sources (news, sec_filing); 2 forward row(s); structured_verified
    Company expects to invest approximately $200 million over the next several years in connection with the Hyderabad project, including both capital expenditures and operating costs.
  5. Revenue Performance and Mix · Revenue growth & mixPriority 64
    +8.3% revenue (realized); 2 sources (news, sec_filing); structured_verified
    Imaging Systems and CAD/CAM services revenues for the three months ended June 30, 2026: $185 million, a decrease of 10.8% year-over-year.
  6. UK VAT Liability · UnclassifiedPriority 56
    2 sources (news, sec_filing); 1 forward row(s); quote_verified
    Align disclosed an estimated $37.5 million UK VAT liability following an adverse tribunal decision.
  7. Capital Return Program · Buybacks & dividendsPriority 55
    -1.5% cash (realized); 2 sources (news, sec_filing); 1 forward row(s); structured_verified
    Company expects to repurchase up to $200 million of common stock over a six-month period beginning on May 1, 2026.
  8. Gross Margin Drivers · Gross marginPriority 54
    +7.0% margin (realized); quote_verified
    In Q2 2026, gross profit was $757.4 million and gross margin was 71.7% compared to $708.1 million and 69.9% in the prior year period.
  9. Operating Expense Trends · Operating expenses (SG&A)Priority 54
    -5.1% operating_income (realized); structured_verified
    2025 restructuring: total incurred restructuring charges as of June 30, 2026: approximately $40.2 million, of which $2.5 million remained unpaid; the 2025 restructuring plan has been completed and the company does not expect to incur additional restructuring expenses in connection with it.
  10. Liquidity and Cash Position · Liquidity & cash positionPriority 49
    +2.6% cash (realized); structured_verified
    Company has access to $300 million under its revolving line of credit.
  11. Guidance and Outlook · Guidance & outlookPriority 44
    1 forward row(s); quote_verified
    Align Technology provided Q3 revenue guidance of $1.01 billion, which fell below analyst estimates.
  12. Market Demand Trends · Demand, orders & backlogPriority 44
    2 sources (news, sec_filing); quote_verified
    Total number of Invisalign-trained doctor submitters in Q2 2026: 89.2 thousand compared to 86.3 thousand in Q2 2025, a 3.4% increase.

Threads by pillar

Revenue & Demand Priority 74 · 3 threads

Costs & Margins Priority 68 · 4 threads

Capital & Balance Sheet Priority 67 · 3 threads

Strategy & Portfolio Priority 68 · 1 thread

Legal, Regulatory & Policy Priority 72 · 2 threads

Guidance & Outlook Priority 44 · 1 thread

Macro & Market Conditions Priority 30 · 2 threads

Unclassified Priority 80 · 3 threads

Expected impact by metric

metricforward netforward grossrealized
cash-3.4%+3.4%-2.2%
operating_income-5.1%
margin+7.0%
net_income-6.6%
revenue+8.3%
liability-0.0%